Close Menu


Genedata has released version 2.0 of its Genedata Biologics data-management product for biologics R&D.

Genedata said this week that MorphoSys has licensed Genedata Biologics, its research and development data management platform, to support efforts to develop therapeutic antibodies.

Genedata Selector is being used by the Integrated Phenotype-Genotype project to analyze and manage data in industrial biotech applications. Meanwhile, Takeda expanded its license for Genedata Expressionist. for proteomic and metabolomic R&D.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Integrated Phenotype-Genotype Project Aims to develop a platform to identify complex genetic effects.

SOAP releases, GenBank 184.0, Ensembl 63, CytoGenomics 1.5, iOmics beta, Genedata Biologics 1.5

UCB will implement a biological registration system for protein-based lead candidates based on Genedata's Biologics software.

Galaxy tool wrappers, ADMET Predictor 5.5, Genedata Biologics, MiMI plugin 3.1

Researchers at Australia's DPI will use the module to analyze plant and animal proteomics and metabolomics datasets with the aim of improving productivity and fighting disease-causing pathogens and parasites.


Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.